It was a much-publicized human vs. computer challenge match—and it wasn’t good for the humans early last year, when the IBM supercomputer Watson handily beat two of Jeopardy’s top human contestants ever to win a $1 million prize. But while Big Blue donated its winnings to charity, the intended benefits of Watson, of course, came … Continue reading “From Jeopardy to Fighting Cancer—IBM’s Watson at XSITE on Thursday”
Category: Boston
Ready or Not, Genomics is Coming to a Hospital Near You
First came genomics for scientists. Then came genomics for Big Pharma. But this year, at a faster pace than many industry insiders anticipated, we’re seeing genomics enter the world of real-life care for patients. This idea would have sounded like science fiction a couple years ago. It took researchers 13 years and about $3 billion … Continue reading “Ready or Not, Genomics is Coming to a Hospital Near You”
Ministry of Supply Puts MIT Engineering Cred Into Dress Shirts
There’s a startup in town that’s turning to Kickstarter—the crowdsourced funding platform—to support its newest product. The team is made up of MIT product designers, engineers, and MBAs, and has tested its technology in MIT labs, even incorporating a coating developed by NASA into its newest product So what is that product, you ask? Men’s … Continue reading “Ministry of Supply Puts MIT Engineering Cred Into Dress Shirts”
Nabeel Hyatt and Mok Oh to Talk Consumer Tech at XSITE 2012
Five words: Nabeel Hyatt and Mok Oh. Five questions: What’s hot in consumer tech? What comes after the lean startup model? How does Nabeel like the VC life? How does Mok like Silicon Valley compared to Boston? What else should we talk about? So many questions, so little time. I’ll be moderating a chat with … Continue reading “Nabeel Hyatt and Mok Oh to Talk Consumer Tech at XSITE 2012”
The TV Revolution Will Be in Slow-Mo, Says Flingo CEO
Henry Blodget, the CEO and editor-in-chief of Business Insider, argued in a column this week that the television industry could suffer a sudden revenue collapse as consumers shift their TV viewing to on-demand, Internet-mediated services like Netflix and iTunes. Blodget thinks network and cable executives are in denial about the danger—just as newspaper publishers were … Continue reading “The TV Revolution Will Be in Slow-Mo, Says Flingo CEO”
Rhythm, Ariad, PerkinElmer, & More Boston Life Sciences Newsmakers
Funding, clinical updates, and a new innovation center made up this week’s New England life sciences news. —In his recent BioBeat column, Xconomy national biotech editor Luke Timmerman explored reasons why biotech startups might change their names. One of the recent examples was Cambridge, MA-based Aveo Oncology (NASDAQ: [[ticker:AVEO]]), which changed its name from Aveo … Continue reading “Rhythm, Ariad, PerkinElmer, & More Boston Life Sciences Newsmakers”
Autodesk Acquires Vela Systems for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=de121ed2-e294-44da-b7b4-b03d63d703cc&Preview=1 Date 6/8/2012 Company Name Vela Systems Mailing Address 164 Middlesex Turnpike Burlington, MA 01803 Company Description Through a unique combination of technical capabilities and deep industry knowledge, Vela Systems empowers the AEC industry with mobile technologies, streamlining field administration processes in construction, capital projects and capital equipment. Vela Systems replaces paper … Continue reading “Autodesk Acquires Vela Systems for Undisclosed Sum”
What’s Actually Interesting About LevelUp: Seth Priebatsch on Money & Merchants
“That’s honestly the least interesting thing we’re up to at the moment,” says Seth Priebatsch of Boston-based startup SCVNGR. And I believe him, mostly. He’s talking about the $12 million financing his company announced today. The money, the first installment of what Priebatsch says will be a larger financing round, comes from a couple of … Continue reading “What’s Actually Interesting About LevelUp: Seth Priebatsch on Money & Merchants”
NEVCA, Common Angels XSITE Startup Tickets Still Up for Grabs
We’re just one week away from the fourth annual Xconomy Summit on Innovation, Technology, and Entrepreneurship, and we are excited to announce that CommonAngels and the New England Venture Capital Association each have five tickets remaining to give away to startups looking to attend the event. The theme of XSITE 2012 is Accelerating Innovation, and … Continue reading “NEVCA, Common Angels XSITE Startup Tickets Still Up for Grabs”
Agrivida Launches Field Production Of Engineered Plants, Plans C Round
Agrivida—the Medford, MA-based startup that is “engineering plants that can break themselves down into sugars,” according to founder and president R. Michael Raab—is scaling up. The startup has been developing its technology in labs and greenhouses since 2003, and earlier this week announced that it had rolled out industrial-sized fields to grow its plants, which … Continue reading “Agrivida Launches Field Production Of Engineered Plants, Plans C Round”
AmberWave Rises Again as Solar Startup: Insights from Investor Russ Wilcox
Has the sun set on the U.S. solar industry? Not in New Hampshire it hasn’t. AmberWave of Salem, NH, has risen from the ashes of AmberWave Systems, a semiconductor company that started in 1998 and shut its doors in 2010 after raising some $91 million to develop “strained silicon” technology for faster and more energy-efficient … Continue reading “AmberWave Rises Again as Solar Startup: Insights from Investor Russ Wilcox”
Adapteva Garners $853,760 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a87e9f0c-a34a-4a3d-868f-27f0e46105e8&Preview=1 Date 6/7/2012 Company Name Adapteva Mailing Address 1666 Massachusetts Ave Lexington, MA 02420 Company Description Adapteva Inc. is a privately held fabless semiconductor company based in Lexington, Massachusetts that has developed the the world’s most energy efficient multicore microprocessors. Website http://www.adapteva.com Transaction Type Debt Transaction Amount $853,760 Transaction Round Undisclosed Proceeds … Continue reading “Adapteva Garners $853,760 New Round”
SCVNGR Garners $12,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=45b6e4f1-2b23-423c-8f78-4382e2f8fe31&Preview=1 Date 6/7/2012 Company Name SCVNGR Mailing Address 175 Second Street Cambridge, MA 02142 Company Description SCVNGR is a geo-gaming platform that enables anyone to quickly and easily build location-based mobile games, tours, and interactive experiences that can be enjoyed from any mobile device. Website http://www.scvngr.com Transaction Type Venture Equity Transaction Amount … Continue reading “SCVNGR Garners $12,000,000 New Funding Round”
Vets First Choice Receives $4,000,000 Series C Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4db70bfc-9dea-45c0-96f2-a3edf0963f10&Preview=1 Date 6/7/2012 Company Name Vets First Choice Mailing Address Undisclosed Portland, ME 04106 Company Description Vets First Choice’s mission is to provide veterinary practices with an outstanding online pharmacy supported by client communications that improve medication compliance, grow practice revenues, and simplify inventory management. Website http://www.myvetsfirstchoice.com Transaction Type Venture Equity Transaction … Continue reading “Vets First Choice Receives $4,000,000 Series C Funding”
Kaminario Lands $25,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4a29ca17-b0fc-4f27-a9eb-e520a5ccfb1f&Preview=1 Date 6/7/2012 Company Name Kaminario Mailing Address 275 Grove St. Newton, MA 02466 Company Description Kaminario boasts world-class system, storage and applications performance professionals, with an experienced management team. Combined, they pool their knowledge and expertise in storage systems, networking, operating systems, BI and data processing to provide cutting edge products … Continue reading “Kaminario Lands $25,000,000 New Funding Round”
Kaminario Lands $25,000,000 Series D Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4a29ca17-b0fc-4f27-a9eb-e520a5ccfb1f&Preview=1 Date 6/7/2012 Company Name Kaminario Mailing Address 275 Grove St. Newton, MA 02466 Company Description Kaminario boasts world-class system, storage and applications performance professionals, with an experienced management team. Combined, they pool their knowledge and expertise in storage systems, networking, operating systems, BI and data processing to provide cutting edge products … Continue reading “Kaminario Lands $25,000,000 Series D Funding”
Emerging Challenges of Prostate Cancer Drug Development
The world’s largest cancer meeting of scientists, physicians and industry has just ended in Chicago. The annual meeting of the American Society of Clinical Oncology (ASCO) attracted over 30,000 attendees to hear leading experts on the latest in cancer drug development. From what I heard at ASCO, biotechnology and pharmaceutical companies with new prostate cancer … Continue reading “Emerging Challenges of Prostate Cancer Drug Development”
Crashlytics Buys FireTower, Gears Up for WWDC Bash as Post-PC Era Dawns
It’s not always the terms of an acquisition that make it interesting. Sometimes it’s the stuff going on around it. That’s usually the case for young, fast-moving fields of technology and business that have yet to coalesce into something stable. And that’s a good thing, because I can’t tell you all that much about the … Continue reading “Crashlytics Buys FireTower, Gears Up for WWDC Bash as Post-PC Era Dawns”
FDA Rejects Ariad/Merck Sarcoma Pill, Wall Street Unfazed
When the FDA gave the thumbs-down last night to ridaforolimus (Taltorvic)—a drug being co-developed by Ariad Pharmaceuticals and Merck to treat metastatic soft-tissue sarcoma or bone sarcoma—investors barely flinched. Shares of Cambridge, MA-based Ariad (NASDAQ: [[ticker:ARIA]]) closed last night at $16.20, dropped a bit in after-hours trading, but were up to $16.68 just after the opening … Continue reading “FDA Rejects Ariad/Merck Sarcoma Pill, Wall Street Unfazed”
Join Us for a Twitter Chat with Atlas Venture’s Fred Destin Today at 3pm ET
If you’ve been wanting to ask Fred Destin something, here’s your chance. I’ll be hosting a 30-minute Twitter chat with the esteemed VC from Atlas Venture today, starting at 3 pm ET. What’s the occasion? Well, Destin will be speaking on a venture panel at XSITE 2012, Xconomy’s biggest conference of the year, on June … Continue reading “Join Us for a Twitter Chat with Atlas Venture’s Fred Destin Today at 3pm ET”
Boston Deals Span Skill Tests, Mobile Offers, and Cloud Archiving
Updated 6/6/12, 4:20 am. See below. New England tech startups took the funding spotlight this week, for their offerings ranging from cloud archiving to online skill tests. —Newton, MA-based cloud archiving startup Sonian raised $13.6 million led by new investor OpenView Venture Partners. The deal also included Sonian investors Prism VentureWorks and Summerhill Venture Partners, and … Continue reading “Boston Deals Span Skill Tests, Mobile Offers, and Cloud Archiving”
Cartera Commerce Lands $12,200,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=de4d5e24-b99a-4831-bcaa-82e7a5c4e0ac&Preview=1 Date 6/6/2012 Company Name Cartera Commerce Mailing Address One Cranberry Hill Lexington, MA 02421 Company Description Cartera Commerce uses the power of affiliate networks to build shopping portals tailor-made for affinity organizations such as school districts, non-profits, sports teams, and consumer associations. With more than 350 of the most trusted online … Continue reading “Cartera Commerce Lands $12,200,000 New Financing Round”
NetProspex Lands $7,000,000 Series B Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3f40bb57-f240-4473-97ee-ab32cef9c6af&Preview=1 Date 6/6/2012 Company Name NetProspex Mailing Address 300 Third Ave Waltham, ME 02451 Company Description Get accurate, targeted contacts for your sales and marketing needs. Find the right person, or people, at a target company who will respond to your message. NetProspex was founded with the mission to provide leads to … Continue reading “NetProspex Lands $7,000,000 Series B Funding Round”
Sand 9 Secures $16,152,715 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=de5a2cc5-b640-4ccf-8a89-a4483a4babac&Preview=1 Date 6/6/2012 Company Name Sand 9 Mailing Address One Kendall Square Cambridge, MA 02139 Company Description Sand 9, Inc. is a venture funded startup company, dedicated to the design of Radio Frequency components that will dramatically improve the performance and increase the capabilities of wireless devices. Our disruptive proprietary technology offers … Continue reading “Sand 9 Secures $16,152,715 New Financing Round”
Nexage Lands $10,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7485471b-2894-47d1-aa84-e99fcb8976b9&Preview=1 Date 6/6/2012 Company Name Nexage Mailing Address 400 Fifth Avenue Waltham, MA 02451 Company Description Nexage is a leading developer of Mobile Advertising solutions that enable companies to maximize Ad revenue from their mobile properties. Its leading product is the AdMax Gateway, a hosted Ad Optimization service that enables carriers and … Continue reading “Nexage Lands $10,000,000 Series B Round”
2012 BIO International Convention
The BIO International Convention draws policy makers, experts, and executives for a packed program exploring biomedical innovations, regulations, and business best practices. Genzyme, Abbott, AstraZeneca, and Bayer are just a few of the organizations represented. Registration is here.
NYC’s Radiator Labs Nabs MIT Clean Tech Prize, Vies for New US Crown
Marshall Cox moved into graduate housing at Columbia University a couple years back and immediately ran into a problem that plagues many New York City residents. His apartment was too hot. Cox couldn’t adjust his radiator because all of the heat for the building came from a single steam generator. So the only way he … Continue reading “NYC’s Radiator Labs Nabs MIT Clean Tech Prize, Vies for New US Crown”
Smarterer Scores Series A, Looks to Replace Resumés with Skill Matching
That Boston tech startup with too many vowels is at it again. Smarterer, a creator of crowdsourced skills tests online, is announcing today a $1.75 million Series A round from previous investors True Ventures and Google Ventures. The deal, which also includes about a dozen angel investors (some of them are new to the company), … Continue reading “Smarterer Scores Series A, Looks to Replace Resumés with Skill Matching”
Cartera Commerce Pockets $12.2M for Card-Linked Deals Tech
Less than a year ago Cartera Commerce CEO Tom Beecher said local merchants were the fastest growing piece of his company, which helps businesses and financial institutions offer card-linked deals to consumers. And now, he says, they’re “a key reason” the company has closed a new $12.2 million round of financing to put toward new … Continue reading “Cartera Commerce Pockets $12.2M for Card-Linked Deals Tech”
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines
There’s so much going on in the world of cancer drug R&D that it’s hard to keep up with all the news about drugs that are changing the standards of care. And quite a few of those standards are changing, based on a quick rundown of what was new at this year’s American Society of … Continue reading “ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines”
Brightcove, Surviving the Recession, Seeks New Fortune in Cloud Content
Whatever happened to Brightcove? You know, the Jeremy Allaire company known for developing a Web video-hosting platform and raising lots of money in the mid-to-late 2000s? Well, for starters, it went public in February with a $55 million IPO. That didn’t begin to match the $103 million it had raised from prominent venture investors, including … Continue reading “Brightcove, Surviving the Recession, Seeks New Fortune in Cloud Content”
FX Aligned Obtains $1,250,001 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1fa51c12-4101-4db0-99a6-549529881299&Preview=1 Date 6/5/2012 Company Name FX Aligned Mailing Address 183 Appletree Point Road Burlington, VT 05408 Company Description FX Aligned Inc., a Vermont startup which will offer services to institutional investors who want to trade on a foreign exchange market. Website http://www.fxaligned.com Transaction Type Venture Equity Transaction Amount $1,250,001 Transaction Round Undisclosed … Continue reading “FX Aligned Obtains $1,250,001 New Financing Round”
Smarterer Lands $1,750,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=30584143-0253-4b03-a724-bb6adb6ffc01&Preview=1 Date 6/5/2012 Company Name Smarterer Mailing Address 500 Harrison Ave. Boston, MA 02118 Company Description Smarterer provides crowd-sourced tests that allow you to get scored and ranked on digital, social, and technical tools. Scores can be shared for reputation, competition, and fun. Add questions to improve your score. Website http://www.smarterer.com Transaction … Continue reading “Smarterer Lands $1,750,000 Series A Financing”
MTLC Seminar: Taking your Agile Development to the Next Level—Best Practices and Methodologies
Developers from companies like Constant Contact and Zynga will shed light on their strategies implementing different development techniques at this MTLC event. Breakout discussions will follow the interactive panel, so sign up here to get in on the action.
MTLC Breakfast Seminar: Business Decisions and Models from the CFO
Chief financial officers from startups like LogMeIn, EnterpriseDB, and Zuora will discuss their methods for scaling software-as-a-service businesses and the spending decisions that come along the way. Register here.
Gemvara Gets $25M More, Goes Big in Online Jewelry
Gemvara continues to raise more venture capital in its quest to become the world’s preeminent jeweler. The Boston-based Web company said today it has raised a $25 million Series D round led by Norwest Venture Partners. Previous investors Highland Capital Partners, Canaan Partners, and Balderton Capital also participated in the round, which brings Gemvara’s total … Continue reading “Gemvara Gets $25M More, Goes Big in Online Jewelry”
TiE Angels Boston, Now in Second Year, Looks to Make More Deals
“Some angel groups tend to have more executives who are high net worth. We tend to have a more entrepreneurial bent,” says Abhishek Jain, chairman of TiE Angels Boston. That sure is an understatement. The “entrepreneurial bent” he refers to includes a couple of inventors extraordinaire who invest as part of the angel group. Like … Continue reading “TiE Angels Boston, Now in Second Year, Looks to Make More Deals”
Building Bridges in a New Global Health Landscape
[Editor’s note: This article is adapted from a speech given at PATH’s annual Breakfast for Global Health on May 22, 2012.] Today I begin a new chapter in my life as president and CEO of the global health organization PATH. Why has this business and social entrepreneur, IP attorney, and human rights activist made this … Continue reading “Building Bridges in a New Global Health Landscape”
Why Would a Biotech Company Go the Trouble of Changing Its Name?
[Updated 1:26 pm PT with survey results] If you’re trying to figure out what the heck a certain biotech company does, the last place to look is usually the company name. Names often don’t mean much, or at least it isn’t obvious. But sometimes you actually can learn a lot about what makes a company … Continue reading “Why Would a Biotech Company Go the Trouble of Changing Its Name?”
Rhythm Pharmaceuticals Garners $9,500,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=43fcab10-5811-4856-aa8b-82b65e8dd713&Preview=1 Date 6/4/2012 Company Name Rhythm Pharmaceuticals Mailing Address 855 Boylston Street, 11th Floor Boston, MA 02116 Company Description Rhythm is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Website http://www.rhythmtx.com Transaction Type Venture Equity Transaction Amount $9,500,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not … Continue reading “Rhythm Pharmaceuticals Garners $9,500,000 New Financing Round”
Gemvara Receives $25,000,000 Series D Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b9085cdf-72c0-4a8c-9e46-8523be244ff8&Preview=1 Date 6/4/2012 Company Name Gemvara Mailing Address 92 Hayden Avenue Lexington, MA 02421 Company Description The term Gemvara is inspired by the ancient Sanskrit word for wish, vara. Every beautiful piece of jewelry that Gemvara sells is available as you wish: customized to suit your style. Website http://www.gemvara.com Transaction Type Venture … Continue reading “Gemvara Receives $25,000,000 Series D Round”
BioBehavioral Diagnostics Secures $5,159,058 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=62fc772e-72da-4b84-b4bc-9994332ec0f3&Preview=1 Date 6/4/2012 Company Name BioBehavioral Diagnostics Mailing Address 239 Littleton Road Westford, MA 01886 Company Description BioBehavioral Diagnostics Company (BioBDx) is a privately held company whose mission is to develop, manufacture, and market proprietary diagnostic systems for the quantitative assessment of behavioral disorders, including the measurement of medication response and the … Continue reading “BioBehavioral Diagnostics Secures $5,159,058 New Round”
Rhythm Pharmaceuticals Secures $25,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=43fcab10-5811-4856-aa8b-82b65e8dd713&Preview=1 Date 6/4/2012 Company Name Rhythm Pharmaceuticals Mailing Address 855 Boylston Street, 11th Floor Boston, MA 02116 Company Description Rhythm is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Website http://www.rhythmtx.com Transaction Type Venture Equity Transaction Amount $25,000,000 Transaction Round Series B Proceeds Purposes Rhythm will use … Continue reading “Rhythm Pharmaceuticals Secures $25,000,000 Series B Financing Round”
J&J Prostate Cancer Trial Shouldn’t Have Been Stopped Early
One of the more anticipated clinical trials at this year’s American Society of Clinical Oncology (ASCO) meeting was for Johnson & Johnson’s abiraterone (Zytiga) in prostate cancer patients. This study, known as COU-AA-302, was stopped early because independent monitors said the drug was clearly effective. But that decision to stop the trial early is questionable, … Continue reading “J&J Prostate Cancer Trial Shouldn’t Have Been Stopped Early”
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Blazes New Trail
Genentech has spent more than a decade developing a souped-up version of its multi-billion dollar breast cancer drug, and today it is delivering hard evidence on cancer R&D’s biggest stage that it works. The South San Francisco-based biotech company, a unit of Roche, has shown that its experimental drug trastuzumab emtansine (T-DM1) hit its main … Continue reading “Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Blazes New Trail”
The Pace of Re-Imagination: We All Live in Dog Years Now
My dog Rhody, an Australian Shepherd, turned 15 a few weeks ago. He’s a living refutation of the old myth that dogs age as much in one year as humans do in seven. By that formula he’d be acting like a doddering 105-year-old, but if you met him you’d agree that he doesn’t seem a … Continue reading “The Pace of Re-Imagination: We All Live in Dog Years Now”
Vertex, N-of-One, Flexion & More Boston Life Sciences News
New England biotechs have been reporting funding, partnership, and clinical trial news this week. —Visterra pulled in $12.9 million of a targeted $19.6 million equity- and options-based funding round, an SEC filing shows. The Cambridge, MA-based startup is developing treatments for infectious diseases. —Xconomy East Coast biotechnology editor Arlene Weintraub took a look at Genentech … Continue reading “Vertex, N-of-One, Flexion & More Boston Life Sciences News”
Seventh Sense Biosystems Secures $200,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f1c9cb68-2f49-4b04-b53c-288324dc586d&Preview=1 Date 6/1/2012 Company Name Seventh Sense Biosystems Mailing Address 286 Cardinal Medeiros Avenue Cambridge, MA 02141 Company Description Seventh Sense Biosystems Inc is a medical device startup company. Website http://www.7sbio.com Transaction Type Debt Transaction Amount $200,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A Terms … Continue reading “Seventh Sense Biosystems Secures $200,000 New Round”
Energy SIG Present: MassCEC Technologies, from University to Startup
Come check out some promising cleantech developments out of the university, at this MIT Enterprise Forum Energy SIG event. Investigators from the Massachusetts Clean Energy Center’s Catalyst Program will talk about how their awards can help accelerate the technologies. Registration is online here.
Bill Warner, Dharmesh Shah Join XSITE 2012 Lineup: Here’s the Agenda
You’ve been waiting for it. We’ve been waiting for it. Here it is: the full agenda for XSITE 2012 on June 14 at Babson College. We’re exactly two weeks out from Xconomy’s biggest innovation conference of the year. We’re really excited to announce that Bill Warner, the angel investor, entrepreneur evangelist, and founder of Avid … Continue reading “Bill Warner, Dharmesh Shah Join XSITE 2012 Lineup: Here’s the Agenda”